查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1794602

患者产生的健康数据的全球市场

Patient Generated Health Data
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 277 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球患者健康数据市场规模将达到 75 亿美元

全球患者产生的健康数据市场规模预计在2024年达到52亿美元，预计2024年至2030年期间的复合年增长率为6.1%，到2030年将达到75亿美元。健身和健康数据是本报告分析的细分市场之一，预计其复合年增长率将达到8.0%，到分析期结束时规模将达到33亿美元。疾病管理资料细分市场在分析期间内的复合年增长率预计为4.5%。

美国市场预计将达到 14 亿美元，而中国市场预计将以 10.0% 的复合年增长率成长

美国患者产生的健康数据市场规模预计在2024年达到14亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到16亿美元，在2024-2030年的分析期间内，复合年增长率为10.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.9%和6.1%。在欧洲，预计德国市场的复合年增长率为4.0%。

全球患者产生的健康数据市场—主要趋势与驱动因素摘要

什么是患者产生的健康数据？为什么它对临床决策有用？

患者产生的健康数据 (PGHD) 是指个人在传统临床环境之外创建、记录或收集的健康相关数据，例如透过穿戴式装置、行动应用程式或个人自述。这些数据包括症状、生活方式行为、生物特征测量、治疗依从性和生活品质指标等资讯。与医生就诊或体检期间获得的数据不同，PGHD 能够持续、即时地洞察患者的日常健康状况。

PGHD 的应用正在改变患者监测和个人化护理的提供方式，尤其是在慢性病管理和预防性护理领域。 PGHD 弥补了临床上的关键空白，使临床医生能够更全面地了解患者的病情进展和行为。随着医疗保健逐渐转向以结果为导向的模式，将 PGHD 纳入护理计划正在提高响应速度、早期疗育以及医患协作。

支援 PGHD 收集和使用的设备、平台和标准如何发展？

技术进步正在提升PGHD的覆盖范围、准确性和易用性。穿戴式装置如今能够监测各种参数，包括心率、血糖浓度、睡眠模式和活动水平，并达到医疗级的精确度。智慧型手机应用程式可让使用者追踪药物摄取量、情绪和饮食习惯。语音辨识工具和智慧家庭设备也有助于以患者友善的方式进行被动数据采集。

为了使PGHD具有临床应用价值，目前正在开发平台，将这些数据以结构化、可解释的格式整合到电子健康记录中。标准化API和资料管治框架正在提升资料安全性、互通性和知情同意管理。临床演算法和仪表板正在设计中，以便医生筛选、优先处理和可视化PGHD，使他们能够应对有意义的变化，而不会被原始数据淹没。

PGHD 的采用在哪里成长以及哪些使用案例引领该应用程式？

PGHD 的应用正在医疗保健系统、健康项目、远端患者监护服务、临床研究等领域不断扩展。北美和欧洲在基础设施准备就绪以及对患者主导数据使用的监管支援方面处于领先地位。随着穿戴式装置和健康应用程式价格越来越低廉且普及，亚太地区正在迅速迎头赶上。

使用案例正在扩展到糖尿病、心血管疾病、心理健康、肿瘤和呼吸系统疾病等疾病。远端患者监测计画依靠 PGHD 来检测早期预警征兆并减少住院治疗。临床试验正在透过患者报告的结果和即时生物识别技术来提高数据准确性和参与者的保留率。保险公司也正在利用 PGHD 来协调健康奖励并更准确地评估风险状况。

患者产生的健康数据市场的成长受到多种因素的推动。

患者产生的健康数据市场的成长受到许多因素的推动，例如可穿戴技术的普及、个人化医疗的日益关注以及持续健康监测需求的不断增长。感测器微型化、行动连线和健康追踪演算法的进步，使得跨人群的数据收集变得可靠且易于使用。

支持远距医疗报销和数位健康记录整合的法律规范正在鼓励医疗机构将 PGHD 纳入日常护理管理。慢性病监测、出院后护理和健康状况追踪正在为 PGHD 创造高度实用的应用。患者意识和自我管理行为的提高进一步促进了数据的丰富，使 PGHD 成为人口健康分析、风险分层和主动护理提供模式的关键输入。

部分

数据类型（健身与健康数据、疾病管理数据、远端监控数据、其他数据类型）、最终用户（医院和诊所最终用户、研究中心最终用户、医疗保健付款人最终用户、其他最终用户）

受访公司范例

  • AliveCor Inc.
  • Allscripts Healthcare Solutions
  • Apple Inc.
  • Athenahealth Inc.
  • Cerner Corporation
  • Dexcom Inc.
  • Epic Systems Corporation
  • Fitbit Inc.
  • HealthMine Inc.
  • Livongo Health（now part of Teladoc）
  • Medidata Solutions
  • Medtronic plc
  • Noom Inc.
  • Omada Health Inc.
  • PatientLikeMe
  • Propeller Health
  • WellDoc Inc.
  • Luscii（Omron）
  • Athelas
  • Kwido

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP37677

Global Patient Generated Health Data Market to Reach US$7.5 Billion by 2030

The global market for Patient Generated Health Data estimated at US$5.2 Billion in the year 2024, is expected to reach US$7.5 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Fitness & Wellness Data, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Disease Management Data segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 10.0% CAGR

The Patient Generated Health Data market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Patient Generated Health Data Market - Key Trends & Drivers Summarized

What Is Patient Generated Health Data and Why Is It Valuable in Clinical Decision Making?

Patient generated health data (PGHD) refers to health-related data created, recorded, or gathered by individuals outside traditional clinical settings, often through wearables, mobile apps, or self-reported inputs. This data includes information on symptoms, lifestyle behaviors, biometric readings, treatment adherence, and quality of life metrics. Unlike data captured during hospital visits or lab tests, PGHD provides continuous, real-time insights into a patient’s day-to-day health status.

The use of PGHD is transforming patient monitoring and personalized care delivery, particularly in chronic disease management and preventive health. It fills important gaps between clinical encounters, offering clinicians a more holistic view of patient progress and behavior. As healthcare moves toward outcome-based models, the inclusion of PGHD in care planning is improving responsiveness, early intervention, and patient-provider collaboration.

How Are Devices, Platforms, and Standards Evolving to Support PGHD Collection and Use?

Technological advancements are enhancing the scope, accuracy, and usability of PGHD. Wearable devices now monitor a wide range of parameters including heart rate, glucose levels, sleep patterns, and activity levels with medical-grade precision. Smartphone applications are allowing users to track medication intake, mood, and dietary habits. Voice recognition tools and smart home devices are also contributing to passive data capture in patient-friendly formats.

To make PGHD clinically relevant, platforms are being developed to integrate this data into electronic health records in structured, interpretable formats. Standardized APIs and data governance frameworks are improving data security, interoperability, and consent management. Clinical algorithms and dashboards are being designed to filter, prioritize, and visualize PGHD for physicians, enabling them to respond to meaningful changes without being overwhelmed by raw data.

Where Is PGHD Adoption Expanding and Which Use Cases Are Leading Application?

PGHD adoption is growing across healthcare systems, wellness programs, remote patient monitoring services, and clinical research. North America and Europe are leading in infrastructure readiness and regulatory support for patient-driven data use. Asia-Pacific is catching up rapidly as wearables and health apps become more affordable and accessible to broad segments of the population.

Use cases are expanding across conditions such as diabetes, cardiovascular disease, mental health, oncology, and respiratory illness. Remote patient monitoring programs rely on PGHD to detect early warning signs and reduce hospital admissions. In clinical trials, patient-reported outcomes and real-time biometrics are improving data accuracy and participant retention. Insurance providers are also utilizing PGHD to tailor wellness incentives and assess risk profiles with greater precision.

Growth in the Patient Generated Health Data market is driven by several factors…

Growth in the patient generated health data market is driven by factors such as rising adoption of wearable technologies, increasing focus on personalized medicine, and growing demand for continuous health monitoring. Advances in sensor miniaturization, mobile connectivity, and health tracking algorithms are enabling reliable, user-friendly data collection across varied demographics.

Regulatory frameworks supporting remote care reimbursement and digital health record integration are encouraging healthcare providers to include PGHD in routine care management. Chronic disease monitoring, post-discharge care, and wellness tracking are creating high-utility application areas for PGHD. Enhanced patient awareness and self-management behaviors are further contributing to data richness, making PGHD a key input for population health analytics, risk stratification, and proactive care delivery models.

SCOPE OF STUDY:

The report analyzes the Patient Generated Health Data market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Data Type (Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data, Other Data Types); End-Use (Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AliveCor Inc.
  • Allscripts Healthcare Solutions
  • Apple Inc.
  • Athenahealth Inc.
  • Cerner Corporation
  • Dexcom Inc.
  • Epic Systems Corporation
  • Fitbit Inc.
  • HealthMine Inc.
  • Livongo Health (now part of Teladoc)
  • Medidata Solutions
  • Medtronic plc
  • Noom Inc.
  • Omada Health Inc.
  • PatientLikeMe
  • Propeller Health
  • WellDoc Inc.
  • Luscii (Omron)
  • Athelas
  • Kwido

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Patient Generated Health Data - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized and Preventive Care Models Spurs Integration of Patient Generated Health Data (PGHD)
    • Expansion of Wearable Devices and Mobile Health Apps Strengthens Data Flow From Patients to Providers
    • Shift Toward Remote Monitoring and Home-Based Care Throws the Spotlight on Real-Time PGHD for Clinical Decision Support
    • Government and Payer Incentives for Chronic Disease Management Encourage Use of PGHD for Outcome-Based Care
    • Advancements in Interoperability and API Integration Improve EMR Compatibility With External Health Data Sources
    • Surge in Consumer Awareness and Digital Health Literacy Supports Active Health Tracking and Data Sharing Behavior
    • Growing Role of AI and Data Analytics Enables Derivation of Actionable Insights From Unstructured PGHD
    • Development of Condition-Specific Tracking Tools Enhances Monitoring of Diabetes, Cardiac Conditions, and Mental Health
    • Patient Empowerment Movements Promote Active Participation in Health Management Through Data Contribution
    • Concerns Over Data Accuracy and Standardization Encourage Investment in Structured Input Tools and Validation Algorithms
    • Integration With Population Health Platforms Enhances Cohort Monitoring and Predictive Modeling
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Patient Generated Health Data Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Patient Generated Health Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Fitness & Wellness Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Fitness & Wellness Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Fitness & Wellness Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disease Management Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Disease Management Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Disease Management Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Remote Monitoring Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Remote Monitoring Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Remote Monitoring Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Data Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Data Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Data Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Healthcare Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Patient Generated Health Data by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Patient Generated Health Data by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Patient Generated Health Data by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Patient Generated Health Data by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION